Polymorphic variants in the PTEN (rs2735343), PI3K (rs2699887), AKT1 (rs2494750), AR (rs17302090), and AMACR (rs3195676) genes were evaluated as possible molecular markers of susceptibility, prognosis, and progression of prostate cancer (PCa), in a case-control study. Samples consisted of 277 patients with PCa and 277 controls from Londrina, PR, Brazil. SNPs were analyzed by real-time PCR. A family history of cancer, including PCa, as well as level of schooling were risk factors for PCa. The data were obtained via logistic regression, using odds ratios with a CI 95%. The genotypes of AKT1 and AKT1+AR demonstrated an association with protection for the disease. The combination of SNPs with the histopathological tumor data between allele variants of AMACR, AKT1+AR, and AKT1+AMACR indicated an association with protection against seminal vesicle invasion. The polymorphisms AKT1+AR and PI3K+AR were associated with protection against tumor bilaterality. The genotype combinations PTEN+AMACR and PTEN+AR were associated with the risk of extracapsular extension. Of the five genes studied, two were associated with protection for PCa, four were associated with protection for some prognostic variables, and only one was associated with risk. Thus, these SNPs are candidates for markers to discriminate men with better or worse prognosis for PCa.
Cellular responses to DNA damage play a crucial role in carcinogenesis, particularly in environmentally related cancers such as bladder cancer (BC). This is the ninth most frequently occurring cancer globally and most frequent in the urinary system. Polymorphic variants in genes encoding DNA repair proteins may interfere with their expression and/or activity. Consequently, modulation in an individual's gene response to exposure might occur resulting in greater susceptibility and lower survival rates in BC. Taking this into account, the study evaluated associations of single-nucleotide polymorphisms (SNPs) in base excision repair genes (XRCC1 rs25487 and OGG1 rs1052133) with BC susceptibility and prognosis. A total of 274 cases and 274 controls, matched on gender, age, and smoking status, were genotyped using DNA from peripheral blood. In susceptibility analyses, individuals with a family history of cancer who carried at least one reference allele (rs1052133, CC + CG) exhibited an increased risk of BC occurrence. For XRCC1, the TT + CC genotypes were associated with elevated risk for BC among pesticide-exposed individuals. Regarding prognosis, the rs1052133 CC genotype was associated with an enhanced risk of recurrence among smokers and female patients. Bioinformatic analyses indicated significantly higher expression of XRCC1 and OGG1 in bladder tissue and marked elevation in expression in tumors. These results suggest that gene-environment interaction might modulate risk of BC occurrence and subsequent prognosis.